ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy
This article has 17 authors:Reviewed by ScreenIT
-
Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike
This article has 4 authors:Reviewed by ScreenIT
-
A novel high-throughput single B-cell cloning platform for isolation and characterization of high-affinity and potent SARS-CoV-2 neutralizing antibodies
This article has 7 authors:Reviewed by ScreenIT
-
Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
This article has 35 authors:Reviewed by ScreenIT
-
Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells
This article has 14 authors:Reviewed by ScreenIT
-
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
This article has 11 authors:Reviewed by ScreenIT
-
Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review
This article has 10 authors:Reviewed by ScreenIT
-
Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
SARS-CoV-2 infections in infants in Haiti 2020–2021; evidence from a seroepidemiological cohort
This article has 11 authors:Reviewed by ScreenIT
-
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
This article has 23 authors:Reviewed by ScreenIT